Source: Marketwatch

TherapeuticsMD: TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains

Company Logo Photo: Terrence Horan Shares of TherapeuticsMD Inc. TXMD +1.20% COMP +0.70% DJIA +0.52% The stock's rise snapped a two-day losing streak. TherapeuticsMD Inc. closed 66.73% below its 52-week high of $2.61, which the company achieved on March 18th. The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. ABBV +1.68% Trading volume (57,265) remained 625,107 below its 50-day average volume of 682,372. Editor's Note: This story was auto-generated by Automated Insights , an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Mark Glickman's photo - Interim Co-CEO of TherapeuticsMD

Interim Co-CEO

Mark Glickman

CEO Approval Rating

- -/100

Read more